Search
Search Results
##search.searchResults.foundPlural##
-
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
1998PDF: 777HTML: 702 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2065PDF: 847HTML: 261 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3354PDF: 1369HTML: 2676 -
The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID VEN/AZA effectively targets AML clones
1278PDF: 773HTML: 321 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
964PDF: 575HTML: 2198Cover Letter: 197 -
SARS-CoV-2 Transmission and Outcome in Neuro-rehabilitation patients hospitalized at Neuroscience Hospital in Italy SARS CoV 2 in severe neurological patients
1100PDF: 720HTML: 220 -
QUALITY OF LIFE ASSESSMENT IN MULTIPLE MYELOMA PATIENTS UNDERGOING DOSE-REDUCED TANDEM AUTOLOGOUS STEM CELL TRANSPLANTATION
1415PDF: 694HTML: 1382cover letter: 215 -
The association of rheumatoid arthritis with glucose- 6-phosphate dehydrogenase deficiency—results from a case-control study. G6PD and Rheumatoid Arthritis
1147PDF: 861HTML: 107 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2642PDF: 1632HTML: 2374Table1: 195 -
WHAT ARE FUNGAL INFECTIONS?
4248PDF: 2418HTML: 27632de Pauw: 244 -
Correlation to FVIII:C in two thrombin generation tests: TGA-CAT and INNOVANCE ETP
2253PDF: 800HTML: 862Figure 2: 218Figure 1: 172 -
Leukocyte derived chemotaxin 2 (ALECT2) amyloidosis
1602PDF: 785HTML: 1311 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1317PDF: 608HTML: 3104 -
ASSESSMENT OF THE EFFICACY OF PROCALCITONIN, C-REACTIVE PROTEIN AND ALBUMIN LEVELS-GUIDED ANTIBIOTICS USE IN SEPSIS
957PDF: 518Html: 146Suppl. Files: 177 -
-
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
4021PDF: 1060HTML: 3604Untitled: 178Cneo. Fig.1: 115Untitled: 108Untitled: 129Untitled: 135 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
8052PDF: 4248HTML: 7511 -
-
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3590PDF: 2515HTML: 1499 -
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3312PDF: 951HTML: 2966 -
CLINICAL AND HEMATOLOGICAL PROFILE OF PATIENTS WITH DENGUE FEVER AT A TERTIARY CARE HOSPITAL – AN OBSERVATIONAL STUDY
4222PDF: 1760HTML: 506Figure 1: Age distribution of Pediatric cases: 223 -
EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT Sinopharm Vaccination in Iranian Patients with Hemoglobinopathies
1707PDF: 738HTML: 236 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2634PDF: 947HTML: 556







